StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The stock has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90.
About Athersys
Further Reading
- Five stocks we like better than Athersys
- Canada Bond Market Holiday: How to Invest and Trade
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- Pros And Cons Of Monthly Dividend Stocks
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
